Quick Read FDA's New Draft Guidance On Data Integrity For In Vivo BABE Studies
The FDA has released a draft guidance, Data Integrity for In Vivo Bioavailability and Bioequivalence Studies. This article shares a concise summary.
Susan Shockey Us Food Drug Administration Human Services Us Food Drug Administration Department Of Health Data Integrity
Source: pharmaceuticalonline.com